Out of over 200+ marijuana stocks, here are 7 of the biggest marijuana stock winners in trading on Monday, November 6th including Aphria Inc. (TSX:APH) (OTC:APHQF) and more...
22nd Century Group, Inc. (NYSE:XXII)
Shares of 22nd Century Group, Inc. rose 10.05% today on lower than average volume, closing the day at $2.19 per share. Due to confusions, many investors assumed that XXII would be releasing its Q3 2017 financial results today, which was not the case.
Aphria Inc. (TSX:APH) (OTC:APHQF)
Shares of Aphria Inc. rose 9.43% today on the OTC markets on higher than average trading volume, closing the day at $6.6328 per share. Last week, the company announced a deal with Resolve Digital Health Inc. which will provide Resolve with a Canadian source of high quality cannabis products, which will be packaged and sold in its proprietary Breeze Smart Inhaler™ metered dosing system pods and cartridges.
Aurora Cannabis Inc. (TSX:ACB) (OTC:ACBFF)
Shares of Aurora Cannabis Inc. rose 11.34% today on the OTC markets on higher than average trading volume, closing the day at $2.75 per share. This morning, the company announced that it finalized a Master Services Agreement with Radient Technologies Inc. where Radient will provide processing services to Aurora for the production of extracts from material supplied by the company.
Cannimed Therapeutics Inc. (TSX:CMED) (OTC:CMMDF)
Shares of Cannimed Therapeutics Inc. rose 9.14% today on the OTC markets on higher than average trading volume, closing the day at $11.0768 per share. recently, the company announced that it received a license from Health Canada to produce medical marijuana capsules.
Canopy Growth Corporation (TSX:WEED) (OTC:TWMJF)
Shares of Canopy Growth Corp. rose 14.91% today on the OTC markets on higher than average trading volume, closing the day at $15.2497 per share. Last week, the company finalized its groundbreaking investment deal with Constellation Brands, the company behind Corona, Modelo and more.
Medreleaf Corp. (TSX:LEAF) (OTC:MEDFF)
Shares of Medreleaf Corp. rose 16.43% today on the OTC markets on higher than average trading volume, closing the day at $12.5104 per share. This morning, the company announced that it was awarded an amended licence from Health Canada to permit sales of medical cannabis under the Access to Cannabis for Medical Purposes Regulations at its second facility in Bradford, ON.
Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE)
Shares of Zynerba Pharmaceuticals, Inc. rose 8.33% today on slightly lower than average volume, closing the day at $11.19 per share. With an upcoming earnings release from ZYNE, many investors have this cannabinoid biotech company on watch.
Find more about today's gainers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.